Literature DB >> 24936335

Clinicopathological features and prognosis of triple negative breast cancer in Kuwait: A comparative/perspective analysis.

Mohammed S Fayaz1, Mustafa S El-Sherify1, Amany El-Basmy2, Sadeq A Zlouf1, Nashwa Nazmy1, Thomas George1, Susan Samir1, Gerges Attia1, Heba Eissa1.   

Abstract

AIM: The aim of this study was to determine the incidence of TNBC in Kuwait, to analyze the clinicopathologic features and prognosis of this type of breast cancer, and compare it with reports from other regions of the world.
BACKGROUND: Triple negative breast cancer (TNBC) is defined as a subtype that is negative for estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2). There is a growing evidence of the heterogeneity of such entity on the molecular level that may cause discrete outcomes.
METHODS: We analyzed the clinicopathologic features of 363 TNBC cases which were diagnosed in Kuwait from July 1999 to June 2009. The disease-free survival (DFS) and overall survival (OS) were analyzed by Kaplan-Meier method. Comparison was done with reports from USA, Europe, Middle and Far East.
RESULTS: Among 2986 patients diagnosed with breast cancer in Kuwait, 363 patients (12.2%) were TNBC. The median age was 48 years, 57.2% had lymph nodes (LN) metastasis, 56.9% were of grade III tumor and 41.9% had stage II disease. 81% developed recurrences and 75% of deaths occurred by 2.5 years after treatment. There is marked variation of clinicopathologic features according to country of patients' cohort.
CONCLUSION: The incidence of TNBC in our study is similar to other studies. TNBC patients showed an early major recurrence surge peaking at approximately year 2.5. Regional variation of clinicopathologic features indicates a need for molecular studies to define underlying molecular features and its impact on survival.

Entities:  

Keywords:  Breast cancer; Clinicopathological; Epidemiology; Triple negative; Variation

Year:  2013        PMID: 24936335      PMCID: PMC4056543          DOI: 10.1016/j.rpor.2013.08.007

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  74 in total

1.  Triple-negative breast cancer in Lebanon: a case series.

Authors:  Marwan Ghosn; Carla Hajj; Joseph Kattan; Fadi Farhat; Fadi El Karak; Fadi Nasr; Gerard Abadjian; Georges Chahine
Journal:  Oncologist       Date:  2011-10-21

Review 2.  Triple-negative breast cancer.

Authors:  William D Foulkes; Ian E Smith; Jorge S Reis-Filho
Journal:  N Engl J Med       Date:  2010-11-11       Impact factor: 91.245

3.  Advanced stages and poorly differentiated grade are associated with an increased risk of HER2/neu positive breast carcinoma only in White women: findings from a prospective cohort study of African-American and White-American women.

Authors:  Azadeh Stark; Alissa Kapke; Daniel Schultz; Ron Brown; Michael Linden; Usha Raju
Journal:  Breast Cancer Res Treat       Date:  2007-04-13       Impact factor: 4.872

4.  Clinical relevance of TNM staging system according to breast cancer subtypes.

Authors:  Y H Park; S J Lee; E Y Cho; Y La Choi; J E Lee; S J Nam; J-H Yang; J H Shin; E Y Ko; B-K Han; J S Ahn; Y-H Im
Journal:  Ann Oncol       Date:  2011-01-17       Impact factor: 32.976

5.  Clinicopathological characteristics of triple-negative invasive mammary carcinomas in African-American versus Caucasian women.

Authors:  Ossama Tawfik; Keisha Davis; Bruce F Kimler; Marilyn K Davis; Stephanie Hull; Fang Fan; Qamar J Khan; Anne P O'Dea; Patricia Thomas
Journal:  Ann Clin Lab Sci       Date:  2010       Impact factor: 1.256

6.  Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Authors:  Martine J Piccart-Gebhart; Marion Procter; Brian Leyland-Jones; Aron Goldhirsch; Michael Untch; Ian Smith; Luca Gianni; Jose Baselga; Richard Bell; Christian Jackisch; David Cameron; Mitch Dowsett; Carlos H Barrios; Günther Steger; Chiun-Shen Huang; Michael Andersson; Moshe Inbar; Mikhail Lichinitser; István Láng; Ulrike Nitz; Hiroji Iwata; Christoph Thomssen; Caroline Lohrisch; Thomas M Suter; Josef Rüschoff; Tamás Suto; Victoria Greatorex; Carol Ward; Carolyn Straehle; Eleanor McFadden; M Stella Dolci; Richard D Gelber
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

Review 7.  A review of triple-negative breast cancer.

Authors:  Roohi Ismail-Khan; Marilyn M Bui
Journal:  Cancer Control       Date:  2010-07       Impact factor: 3.302

8.  Age distribution of breast cancer in Lebanon: increased percentages and age adjusted incidence rates of younger-aged groups at presentation.

Authors:  Nagi S El Saghir; Ali I Shamseddine; Fady Geara; Kamal Bikhazi; Boushra Rahal; Ziad M K Salem; Ali Taher; Ayman Tawil; Ziad El Khatib; Jaber Abbas; Mukbil Hourani; Moheiddine Seoud
Journal:  J Med Liban       Date:  2002 Jan-Apr

Review 9.  Evaluation of morphologic features to identify "basal-like phenotype" on core needle biopsies of breast.

Authors:  Mamatha Chivukula; Joan M Striebel; Cağatay Erşahin; David J Dabbs
Journal:  Appl Immunohistochem Mol Morphol       Date:  2008-10

10.  The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer.

Authors:  Jiyoung Rhee; Sae-Won Han; Do-Youn Oh; Jee Hyun Kim; Seock-Ah Im; Wonshik Han; In Ae Park; Dong-Young Noh; Yung-Jue Bang; Tae-You Kim
Journal:  BMC Cancer       Date:  2008-10-23       Impact factor: 4.430

View more
  4 in total

1.  Clinicopathological Features of Triple Negative Breast Carcinoma.

Authors:  Gowry Maram Reddy; Pooja K Suresh; Radha R Pai
Journal:  J Clin Diagn Res       Date:  2017-01-01

2.  Lx2-32c-loaded polymeric micelles with small size for intravenous drug delivery and their inhibitory effect on tumor growth and metastasis in clinically associated 4T1 murine breast cancer.

Authors:  Li-Qing Chen; Wei Huang; Zhong-Gao Gao; Wei-Shuo Fang; Ming-Ji Jin
Journal:  Int J Nanomedicine       Date:  2016-10-19

Review 3.  Breast Cancer in Asia: Incidence, Mortality, Early Detection, Mammography Programs, and Risk-Based Screening Initiatives.

Authors:  Yu Xian Lim; Zi Lin Lim; Peh Joo Ho; Jingmei Li
Journal:  Cancers (Basel)       Date:  2022-08-30       Impact factor: 6.575

4.  KEGG-expressed genes and pathways in triple negative breast cancer: Protocol for a systematic review and data mining.

Authors:  Jiarui Chen; Chong Liu; Jiemei Cen; Tuo Liang; Jiang Xue; Haopeng Zeng; Zide Zhang; Guoyong Xu; Chaojie Yu; Zhaojun Lu; Zequn Wang; Jie Jiang; Xinli Zhan; Jian Zeng
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.